Judge: Investors Failed To Show Involvement In Market Manipulation Scheme
NEW YORK — Shareholders have failed to show that a biopharmaceutical company and certain of its executive officers and directors engaged in a market manipulation scheme because the shareholders failed to...To view the full article, register now.
Already a subscriber? Click here to view full article